Leading global professional services firm Alvarez & Marsal (A&M) announced the appointment of Ashish Bansal as a Managing Director and Co-leader of its India Global Transaction Advisory Group (TAG) practice, alongside Mumbai-based, Managing Director, Bhavik Hathi.

In a recent article by Automotive News, Brian Irwin sheds light on the outlook of the electric vehicle industry.

The financial health of companies in the electric power space is critical for the energy transition, making climate resilience essential for achieving broader decarbonization goals.

A&M Managing Director Al Carnrite was recently featured in WSJ Pro: Private Equity: "Former Warburg Pincus Executives' New Firm Seeks $750 Million for Oil-and-Gas Bets"

This report was first published in Mealey’s Litigation Report: Artificial Intelligence.

A&M Tax welcomes Managing Director Scott Moresco to the Global Transaction Tax Advisory team. Mr. Moresco brings 38 years of advisory experience on tax issues associated with company restructurings, both in and out of bankruptcy.

On November 22, 2023, Chancellor Jeremy Hunt presented the UK's Autumn Budget.

After enjoying strong tailwinds over the past decade, private markets players have had to navigate a very different environment in 2023. This year will likely be remembered for the slowdown in buyouts, depressed exit activity and fundraising pressures that have followed the new macroeconomic reality of higher interest rates, rising inflation and slower growth.

In Part 2 of this series, A&M Director Ben Wilson explores the innovative use of Combinatorial Clock Acquisitions (CCAs), showcasing their unparalleled ability to streamline government procurement processes and amplify efficiency. 

Leading global professional services firm Alvarez & Marsal (A&M) has strengthened its tax advisory team with the appointments of Andy Murray and Prasam Patel as Managing Directors.

Against a backdrop of prevailing macroeconomic headwinds, including high energy prices, constrained global supply chains and a 40-year high inflation rate, the MedTech industry has continued to demonstrate resilience with revenues forecasted to increase by 4.2% from 2022. In contrast, the UK’s GDP is only expected to grow 0.6% in 2023. MedTech’s and indeed the broader Healthcare and Life Sciences sector’s superior growth is being driven by key trends.